Pathogenesis of accelerated fibrosis in HIV/HCV co-infection

Journal of Infectious Diseases

Volumn 207, Issue SUPPL.1, 2013, Pages

  Lin, Wenyu ^a   Weinberg, Ethan M ^b   Chung, Raymond T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Hepatic Fibrogenesis; Hepatitis C Virus (HCV); Human Immunodeficiency Virus (HIV)

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CD4 LYMPHOCYTE COUNT; CYTOKINE RELEASE; DISEASE CONTROL; DISEASE COURSE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MIXED INFECTION; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

APOPTOSIS; BACTERIAL TRANSLOCATION; COINFECTION; CYTOKINES; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; OXIDATIVE STRESS;

EID: 84873587751     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis926     Document Type: Review

References (28)

1. Kim AY, Chung RT. Coinfection with HIV-1 and HCV-a one-two punch. Gastroenterology 2009; 137:795-814.
2. Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol 2009; 83:7366-74.
3. Sherman KE, Thomas DL, Chung RT. Human immunodeficiency virus and liver disease forum 2010: conference proceedings. Hepatology 2011; 54:2245-53.
4. Hernando V, Perez-Cachafeiro S, Lewden C, et al. All-cause and liverrelated mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection. J Hepatol 2012; 57:743-51.
5. Chen TY, Ding EL, Seage Iii GR, Kim AY. Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009; 49:1605-15.
6. Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24:1537-48.
7. Macias J, Berenguer J, Japon MA, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 2009; 50:1056-63.
8. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054-8.
9. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41:779-89.
10. Brau N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47:527-37.
11. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6:425-56.
12. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:1655-69.
13. Lin W, Tsai WL, Shao RX, et al. Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor κB-dependent manner. Gastroenterology 2010; 138:2509-18, 2518 e1.
14. Choi J. Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations. Free Radic Biol Med 2012; 52:1135-50.
15. Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, et al. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signaling alterations in hepatocytes. J Hepatol 2009; 50:872-82.
16. Lin W, Weinberg EM, Tai AW, et al. HIV increases HCV replication in a TGF-β1-dependent manner. Gastroenterology 2008; 134:803-11.
17. Lin W, Wu G, Li S, et al. HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFκB. J Biol Chem 2011; 286:2665-74.
18. Tuyama AC, Hong F, Saiman Y, et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 2010; 52:612-22.
19. Bruno R, Galastri S, Sacchi P, et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 2010; 59:513-20.
20. Hong F, Tuyama A, Lee TF, et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology 2009; 49:2055-67.
21. Presser LD, Haskett A, Waris G. Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: role of TGF-β1 in HCV replication. Virology 2011; 412:284-96.
22. Jang JY, Shao RX, Lin W, et al. HIV infection increases HCV-induced hepatocyte apoptosis. J Hepatol 2011; 54:612-20.
23. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71.
24. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 2007; 13:1324-32.
25. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to- platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 2012; 205:1005-13.
26. Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011; 141:1220-30, 1230 e1-3.
27. Balagopal A, Philp FH, Astemborski J, et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 2008; 135:226-33.
28. Balagopal A, Ray SC, De Oca RM, et al. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. AIDS 2009; 23:2397-404.